Profiling Symptomatic and Quality of Life Benefits of Mepolizumab for Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) in the SYNAPSE Trial Meeting Abstract

publication date

  • February 1, 2024

webpage

start page

  • AB252

end page

  • AB252

volume

  • 153

issue

  • 2